Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Traumatic Brain Injury (tbi) Patients Clinical Trials

5 recruiting trials for Traumatic Brain Injury (tbi) Patients. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
5
Total Trials
5
Recruiting Now
0
Phase 3 Trials
5
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 4NCT07072624

Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)

Rationale/gaps in existing knowledge: The prophylaxis for post-traumatic seizures (PTS) remains controversial due to a lack of class I evidence. Investigators plan to conduct a...

Sponsor: All India Institute of Medical Sciences, JodhpurEnrolling: 12603 locations
RECRUITINGNCT07474987

Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury

Accurate and non-invasive methods for objectively identifying and monitoring head injuries (such as a concussion) are still an unmet need. It is known that pupil constriction in...

Sponsor: Sheba Medical CenterEnrolling: 1501 location
RECRUITINGNCT06734026

Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury

The goal of this study is to learn if a enhanced environment (Metro Café) with multi model approach (an approach that combines several therapies) in chronic traumatic brain injury...

Sponsor: MetroHealth Medical CenterEnrolling: 201 location
RECRUITINGNCT06723743

Transcutaneous Vagus Nerve Stimulation for Attention and Memory

This clinical trial aims to evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive brain stimulation method, can improve attention and memory in...

Sponsor: Baylor College of MedicineEnrolling: 302 locations
RECRUITINGNCT07292766

Metabolomic Profiling of Patients With Traumatic Brain Injury

Traumatic Brain Injury (TBI) is a significant cause of mortality and morbidity worldwide. However, the literature on determining its severity and predicting prognosis is...

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalEnrolling: 601 location

Frequently Asked Questions

There are currently 5 clinical trials for Traumatic Brain Injury (tbi) Patients, with 5 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Traumatic Brain Injury (tbi) Patients, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Traumatic Brain Injury (tbi) Patients, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.

The this entity record above pulls directly from the NIH ClinicalTrials.gov registry. What follows is the per-entity context — how this entity sits in the broader U.S. clinical trials and research registries distribution and which underlying factors drive the headline numbers.

Every number on this page links back to the NIH ClinicalTrials.gov registry; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within active and historical clinical trials with similar size, similar exposure, or similar geography — not the national-level summary alone.